Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-21-004152)

Filing Details

Accession Number:: 0001562180-21-004152
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-09 16:26:29
Reporting Period:: 2021-06-07

Accepted Time:: 2021-06-09 16:26:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1517022	Akebia Therapeutics Inc.	AKBA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1379970	C Steven Gilman	C/O Akebia Therapeutics, Inc. 245 First St. Cambridge MA 02142		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-06-07	4,567	$3.32	47,997	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 5, 2020.
This transaction was executed in multiple trades at prices ranging from $3.3201 USD to $3.325 USD; the price reported above reflects the weighted average sale price.